Patent ID: 8802631

Claim:
A method for the treatment of cancer, which comprises administering to a patient in need thereof an effective amount of a peptide that inhibits the interaction between PrP C and Hop, thus inhibiting the Hop-induced proliferation of the cancer cells, wherein the peptide is selected from the group consisting of ELGNDAYKKKDFDKAL (SEQ ID NO: 1), ELGNDAYKKKDFDTAL (SEQ ID NO: 2), YGRKKRRQRRRELGNDAYKKKDFDTAL (SEQ ID NO: 10), YGRKKRRQRRRELGNDAYKKKDFDKAL (SEQ ID NO: 9), TFFYGGCRGKRNNFKTEEYELGNDAYKKKDFDTAL (SEQ ID NO: 12), and TFFYGGCRGKRNNFKTEEYELGNDAYKKKDFDKAL (SEQ ID NO: 13).